nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—CYP3A4—prostate cancer	0.0802	1	CbGaD
Levothyroxine—SLCO4A1—Conjugated Estrogens—prostate cancer	0.0636	0.0988	CbGbCtD
Levothyroxine—SLCO4A1—Estradiol—prostate cancer	0.0558	0.0867	CbGbCtD
Levothyroxine—SLCO1C1—Conjugated Estrogens—prostate cancer	0.0446	0.0694	CbGbCtD
Levothyroxine—SLCO1C1—Estradiol—prostate cancer	0.0392	0.0609	CbGbCtD
Levothyroxine—SLCO1B3—Cabazitaxel—prostate cancer	0.039	0.0606	CbGbCtD
Levothyroxine—SLCO1B3—Conjugated Estrogens—prostate cancer	0.0249	0.0387	CbGbCtD
Levothyroxine—SLCO1A2—Estrone—prostate cancer	0.0235	0.0365	CbGbCtD
Levothyroxine—SLCO1B1—Cabazitaxel—prostate cancer	0.0227	0.0353	CbGbCtD
Levothyroxine—SLCO1B1—Estrone—prostate cancer	0.0222	0.0345	CbGbCtD
Levothyroxine—SLCO1B3—Estradiol—prostate cancer	0.0219	0.034	CbGbCtD
Levothyroxine—ALB—Abiraterone—prostate cancer	0.0168	0.0261	CbGbCtD
Levothyroxine—CYP2C8—Nilutamide—prostate cancer	0.0157	0.0244	CbGbCtD
Levothyroxine—SLCO1A2—Conjugated Estrogens—prostate cancer	0.0154	0.0239	CbGbCtD
Levothyroxine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0145	0.0226	CbGbCtD
Levothyroxine—SLCO1A2—Estradiol—prostate cancer	0.0135	0.021	CbGbCtD
Levothyroxine—SLCO1B3—Docetaxel—prostate cancer	0.0131	0.0203	CbGbCtD
Levothyroxine—CYP2C8—Abiraterone—prostate cancer	0.013	0.0202	CbGbCtD
Levothyroxine—SLCO1B1—Estradiol—prostate cancer	0.0127	0.0198	CbGbCtD
Levothyroxine—ALB—Estrone—prostate cancer	0.0122	0.0189	CbGbCtD
Levothyroxine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0121	0.0188	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—prostate cancer	0.0116	0.0181	CbGbCtD
Levothyroxine—ABCB1—Estramustine—prostate cancer	0.00986	0.0153	CbGbCtD
Levothyroxine—CYP2C8—Cabazitaxel—prostate cancer	0.00961	0.0149	CbGbCtD
Levothyroxine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00837	0.013	CbGbCtD
Levothyroxine—ALB—Estradiol—prostate cancer	0.00698	0.0108	CbGbCtD
Levothyroxine—ABCB1—Cabazitaxel—prostate cancer	0.0065	0.0101	CbGbCtD
Levothyroxine—CYP3A4—Bicalutamide—prostate cancer	0.00636	0.00988	CbGbCtD
Levothyroxine—ABCB1—Estrone—prostate cancer	0.00636	0.00988	CbGbCtD
Levothyroxine—ALB—Prednisone—prostate cancer	0.006	0.00933	CbGbCtD
Levothyroxine—CYP3A4—Estramustine—prostate cancer	0.00591	0.00918	CbGbCtD
Levothyroxine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00566	0.0088	CbGbCtD
Levothyroxine—CYP2C8—Estradiol—prostate cancer	0.00539	0.00838	CbGbCtD
Levothyroxine—CYP3A4—Abiraterone—prostate cancer	0.00527	0.00819	CbGbCtD
Levothyroxine—CYP3A4—Flutamide—prostate cancer	0.00527	0.00819	CbGbCtD
Levothyroxine—TTR—urine—prostate cancer	0.00437	0.0866	CbGeAlD
Levothyroxine—ABCB1—Conjugated Estrogens—prostate cancer	0.00416	0.00646	CbGbCtD
Levothyroxine—CYP3A4—Cabazitaxel—prostate cancer	0.0039	0.00605	CbGbCtD
Levothyroxine—CYP3A4—Estrone—prostate cancer	0.00381	0.00592	CbGbCtD
Levothyroxine—ABCB1—Mitoxantrone—prostate cancer	0.00378	0.00587	CbGbCtD
Levothyroxine—ABCB1—Estradiol—prostate cancer	0.00365	0.00567	CbGbCtD
Levothyroxine—CYP2C8—Etoposide—prostate cancer	0.00352	0.00547	CbGbCtD
Levothyroxine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00339	0.00527	CbGbCtD
Levothyroxine—ABCB1—Prednisone—prostate cancer	0.00314	0.00488	CbGbCtD
Levothyroxine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00249	0.00387	CbGbCtD
Levothyroxine—ABCB1—Etoposide—prostate cancer	0.00238	0.0037	CbGbCtD
Levothyroxine—CYP3A4—Mitoxantrone—prostate cancer	0.00226	0.00352	CbGbCtD
Levothyroxine—CYP3A4—Estradiol—prostate cancer	0.00219	0.0034	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—prostate cancer	0.00218	0.00339	CbGbCtD
Levothyroxine—THRB—prostate gland—prostate cancer	0.00211	0.0418	CbGeAlD
Levothyroxine—THRA—prostate gland—prostate cancer	0.00211	0.0418	CbGeAlD
Levothyroxine—SLC16A2—prostate gland—prostate cancer	0.00191	0.0379	CbGeAlD
Levothyroxine—CYP3A4—Prednisone—prostate cancer	0.00188	0.00292	CbGbCtD
Levothyroxine—SLCO4C1—seminal vesicle—prostate cancer	0.00186	0.0369	CbGeAlD
Levothyroxine—SERPINA7—bone marrow—prostate cancer	0.00176	0.0349	CbGeAlD
Levothyroxine—ABCB1—Doxorubicin—prostate cancer	0.00163	0.00253	CbGbCtD
Levothyroxine—SLC7A5—prostate gland—prostate cancer	0.00161	0.0319	CbGeAlD
Levothyroxine—SLCO4C1—renal system—prostate cancer	0.0015	0.0297	CbGeAlD
Levothyroxine—THRB—renal system—prostate cancer	0.00144	0.0285	CbGeAlD
Levothyroxine—THRA—renal system—prostate cancer	0.00144	0.0285	CbGeAlD
Levothyroxine—CYP3A4—Etoposide—prostate cancer	0.00143	0.00222	CbGbCtD
Levothyroxine—SLCO4A1—prostate gland—prostate cancer	0.0014	0.0279	CbGeAlD
Levothyroxine—SLC7A5—seminal vesicle—prostate cancer	0.00136	0.027	CbGeAlD
Levothyroxine—CYP3A4—urine—prostate cancer	0.00133	0.0263	CbGeAlD
Levothyroxine—CYP3A4—Docetaxel—prostate cancer	0.00131	0.00203	CbGbCtD
Levothyroxine—SLC16A2—urethra—prostate cancer	0.00128	0.0254	CbGeAlD
Levothyroxine—SLCO1C1—renal system—prostate cancer	0.00119	0.0237	CbGeAlD
Levothyroxine—SLCO4A1—seminal vesicle—prostate cancer	0.00119	0.0236	CbGeAlD
Levothyroxine—SLC7A5—epithelium—prostate cancer	0.00118	0.0235	CbGeAlD
Levothyroxine—SLCO4C1—bone marrow—prostate cancer	0.00113	0.0225	CbGeAlD
Levothyroxine—SLC7A5—urethra—prostate cancer	0.00108	0.0214	CbGeAlD
Levothyroxine—TTR—renal system—prostate cancer	0.00107	0.0212	CbGeAlD
Levothyroxine—CYP3A4—Doxorubicin—prostate cancer	0.000974	0.00151	CbGbCtD
Levothyroxine—SLCO4A1—renal system—prostate cancer	0.000957	0.019	CbGeAlD
Levothyroxine—SLCO4A1—urethra—prostate cancer	0.000941	0.0187	CbGeAlD
Levothyroxine—THRA—testis—prostate cancer	0.000929	0.0184	CbGeAlD
Levothyroxine—THRB—testis—prostate cancer	0.000929	0.0184	CbGeAlD
Levothyroxine—SLCO1B1—renal system—prostate cancer	0.000843	0.0167	CbGeAlD
Levothyroxine—SLC16A2—testis—prostate cancer	0.000842	0.0167	CbGeAlD
Levothyroxine—SLC7A5—bone marrow—prostate cancer	0.000829	0.0164	CbGeAlD
Levothyroxine—TTR—bone marrow—prostate cancer	0.000808	0.016	CbGeAlD
Levothyroxine—SLCO1C1—testis—prostate cancer	0.000772	0.0153	CbGeAlD
Levothyroxine—SLC7A5—testis—prostate cancer	0.000709	0.0141	CbGeAlD
Levothyroxine—TTR—testis—prostate cancer	0.00069	0.0137	CbGeAlD
Levothyroxine—SLCO1A2—renal system—prostate cancer	0.000686	0.0136	CbGeAlD
Levothyroxine—THRA—lymph node—prostate cancer	0.000673	0.0134	CbGeAlD
Levothyroxine—THRB—lymph node—prostate cancer	0.000673	0.0134	CbGeAlD
Levothyroxine—SLCO4A1—testis—prostate cancer	0.000619	0.0123	CbGeAlD
Levothyroxine—SLC16A2—lymph node—prostate cancer	0.00061	0.0121	CbGeAlD
Levothyroxine—SLCO1C1—lymph node—prostate cancer	0.00056	0.0111	CbGeAlD
Levothyroxine—SLC7A5—lymph node—prostate cancer	0.000514	0.0102	CbGeAlD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—prostate cancer	0.000503	1	CbGdCrCtD
Levothyroxine—CYP2C8—renal system—prostate cancer	0.000479	0.0095	CbGeAlD
Levothyroxine—SLCO4A1—lymph node—prostate cancer	0.000449	0.0089	CbGeAlD
Levothyroxine—SLCO1A2—testis—prostate cancer	0.000443	0.00879	CbGeAlD
Levothyroxine—ALB—testis—prostate cancer	0.000441	0.00874	CbGeAlD
Levothyroxine—ABCB1—prostate gland—prostate cancer	0.000337	0.00669	CbGeAlD
Levothyroxine—CYP3A4—renal system—prostate cancer	0.000324	0.00644	CbGeAlD
Levothyroxine—ALB—lymph node—prostate cancer	0.000319	0.00634	CbGeAlD
Levothyroxine—CYP2C8—testis—prostate cancer	0.00031	0.00614	CbGeAlD
Levothyroxine—ABCB1—seminal vesicle—prostate cancer	0.000285	0.00565	CbGeAlD
Levothyroxine—ABCB1—epithelium—prostate cancer	0.000248	0.00491	CbGeAlD
Levothyroxine—ABCB1—renal system—prostate cancer	0.00023	0.00456	CbGeAlD
Levothyroxine—ABCB1—urethra—prostate cancer	0.000226	0.00448	CbGeAlD
Levothyroxine—ABCB1—bone marrow—prostate cancer	0.000174	0.00345	CbGeAlD
Levothyroxine—ABCB1—testis—prostate cancer	0.000148	0.00295	CbGeAlD
Levothyroxine—Hyperhidrosis—Estradiol—prostate cancer	0.000129	0.00104	CcSEcCtD
Levothyroxine—Rash—Ethinyl Estradiol—prostate cancer	0.000129	0.00104	CcSEcCtD
Levothyroxine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000129	0.00104	CcSEcCtD
Levothyroxine—Alopecia—Etoposide—prostate cancer	0.000128	0.00104	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Capecitabine—prostate cancer	0.000128	0.00104	CcSEcCtD
Levothyroxine—Headache—Ethinyl Estradiol—prostate cancer	0.000128	0.00103	CcSEcCtD
Levothyroxine—Myocardial infarction—Capecitabine—prostate cancer	0.000128	0.00103	CcSEcCtD
Levothyroxine—Sweating increased—Prednisone—prostate cancer	0.000127	0.00102	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—prostate cancer	0.000125	0.00101	CcSEcCtD
Levothyroxine—Confusional state—Mitoxantrone—prostate cancer	0.000125	0.00101	CcSEcCtD
Levothyroxine—Shock—Mitoxantrone—prostate cancer	0.000122	0.000985	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.000121	0.000979	CcSEcCtD
Levothyroxine—Nausea—Ethinyl Estradiol—prostate cancer	0.000121	0.000979	CcSEcCtD
Levothyroxine—Tachycardia—Mitoxantrone—prostate cancer	0.000121	0.000978	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—prostate cancer	0.000121	0.000974	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—prostate cancer	0.000121	0.000974	CcSEcCtD
Levothyroxine—Asthenia—Goserelin—prostate cancer	0.000121	0.000973	CcSEcCtD
Levothyroxine—Insomnia—Estradiol—prostate cancer	0.00012	0.000972	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—prostate cancer	0.00012	0.000969	CcSEcCtD
Levothyroxine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.00012	0.000968	CcSEcCtD
Levothyroxine—Asthenia—Conjugated Estrogens—prostate cancer	0.000119	0.000964	CcSEcCtD
Levothyroxine—Pruritus—Goserelin—prostate cancer	0.000119	0.000959	CcSEcCtD
Levothyroxine—Dyspnoea—Estradiol—prostate cancer	0.000119	0.000958	CcSEcCtD
Levothyroxine—Pruritus—Conjugated Estrogens—prostate cancer	0.000118	0.00095	CcSEcCtD
Levothyroxine—Weight decreased—Prednisone—prostate cancer	0.000118	0.00095	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—prostate cancer	0.000116	0.000936	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—prostate cancer	0.000116	0.000935	CcSEcCtD
Levothyroxine—Diarrhoea—Goserelin—prostate cancer	0.000115	0.000928	CcSEcCtD
Levothyroxine—Fatigue—Estradiol—prostate cancer	0.000115	0.000927	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Prednisone—prostate cancer	0.000114	0.000923	CcSEcCtD
Levothyroxine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000114	0.000919	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisone—prostate cancer	0.000114	0.000918	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000113	0.000913	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—prostate cancer	0.000112	0.000904	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—prostate cancer	0.000112	0.000904	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—prostate cancer	0.000112	0.000901	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—prostate cancer	0.000112	0.000901	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—prostate cancer	0.000112	0.0009	CcSEcCtD
Levothyroxine—Dyspnoea—Mitoxantrone—prostate cancer	0.000111	0.000893	CcSEcCtD
Levothyroxine—Feeling abnormal—Estradiol—prostate cancer	0.00011	0.000886	CcSEcCtD
Levothyroxine—Convulsion—Etoposide—prostate cancer	0.00011	0.000884	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—prostate cancer	0.00011	0.000884	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Estradiol—prostate cancer	0.000109	0.000879	CcSEcCtD
Levothyroxine—Flushing—Capecitabine—prostate cancer	0.000109	0.000876	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—prostate cancer	0.000108	0.000871	CcSEcCtD
Levothyroxine—ABCB1—lymph node—prostate cancer	0.000108	0.00213	CbGeAlD
Levothyroxine—Affect lability—Doxorubicin—prostate cancer	0.000107	0.000865	CcSEcCtD
Levothyroxine—Fatigue—Mitoxantrone—prostate cancer	0.000107	0.000864	CcSEcCtD
Levothyroxine—Vomiting—Goserelin—prostate cancer	0.000107	0.000862	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—prostate cancer	0.000107	0.000861	CcSEcCtD
Levothyroxine—Rash—Goserelin—prostate cancer	0.000106	0.000855	CcSEcCtD
Levothyroxine—Dermatitis—Goserelin—prostate cancer	0.000106	0.000854	CcSEcCtD
Levothyroxine—Vomiting—Conjugated Estrogens—prostate cancer	0.000106	0.000854	CcSEcCtD
Levothyroxine—Urticaria—Estradiol—prostate cancer	0.000106	0.000854	CcSEcCtD
Levothyroxine—Body temperature increased—Estradiol—prostate cancer	0.000105	0.00085	CcSEcCtD
Levothyroxine—Abdominal pain—Estradiol—prostate cancer	0.000105	0.00085	CcSEcCtD
Levothyroxine—Headache—Goserelin—prostate cancer	0.000105	0.000849	CcSEcCtD
Levothyroxine—Rash—Conjugated Estrogens—prostate cancer	0.000105	0.000847	CcSEcCtD
Levothyroxine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000105	0.000846	CcSEcCtD
Levothyroxine—Arrhythmia—Capecitabine—prostate cancer	0.000104	0.000843	CcSEcCtD
Levothyroxine—Headache—Conjugated Estrogens—prostate cancer	0.000104	0.000841	CcSEcCtD
Levothyroxine—Confusional state—Etoposide—prostate cancer	0.000104	0.00084	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—prostate cancer	0.000104	0.000838	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—prostate cancer	0.000104	0.000836	CcSEcCtD
Levothyroxine—Alopecia—Capecitabine—prostate cancer	0.000103	0.000834	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—prostate cancer	0.000103	0.000833	CcSEcCtD
Levothyroxine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000102	0.000825	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—prostate cancer	0.000102	0.000821	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000101	0.000819	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—prostate cancer	0.000101	0.000818	CcSEcCtD
Levothyroxine—Tachycardia—Etoposide—prostate cancer	0.000101	0.000813	CcSEcCtD
Levothyroxine—Nausea—Goserelin—prostate cancer	9.98e-05	0.000805	CcSEcCtD
Levothyroxine—Hyperhidrosis—Etoposide—prostate cancer	9.98e-05	0.000805	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—prostate cancer	9.91e-05	0.0008	CcSEcCtD
Levothyroxine—Nausea—Conjugated Estrogens—prostate cancer	9.89e-05	0.000798	CcSEcCtD
Levothyroxine—Urticaria—Mitoxantrone—prostate cancer	9.86e-05	0.000796	CcSEcCtD
Levothyroxine—Abdominal pain—Mitoxantrone—prostate cancer	9.81e-05	0.000792	CcSEcCtD
Levothyroxine—Body temperature increased—Mitoxantrone—prostate cancer	9.81e-05	0.000792	CcSEcCtD
Levothyroxine—Flushing—Prednisone—prostate cancer	9.67e-05	0.00078	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—prostate cancer	9.61e-05	0.000775	CcSEcCtD
Levothyroxine—Asthenia—Estradiol—prostate cancer	9.56e-05	0.000771	CcSEcCtD
Levothyroxine—Tremor—Capecitabine—prostate cancer	9.54e-05	0.00077	CcSEcCtD
Levothyroxine—Pruritus—Estradiol—prostate cancer	9.42e-05	0.000761	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—prostate cancer	9.42e-05	0.00076	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisone—prostate cancer	9.3e-05	0.000751	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—prostate cancer	9.29e-05	0.00075	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—prostate cancer	9.21e-05	0.000743	CcSEcCtD
Levothyroxine—Dyspnoea—Etoposide—prostate cancer	9.2e-05	0.000743	CcSEcCtD
Levothyroxine—Alopecia—Prednisone—prostate cancer	9.2e-05	0.000743	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—prostate cancer	9.17e-05	0.00074	CcSEcCtD
Levothyroxine—Diarrhoea—Estradiol—prostate cancer	9.11e-05	0.000736	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—prostate cancer	9.11e-05	0.000735	CcSEcCtD
Levothyroxine—Palpitations—Capecitabine—prostate cancer	9e-05	0.000726	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—prostate cancer	8.95e-05	0.000722	CcSEcCtD
Levothyroxine—Asthenia—Mitoxantrone—prostate cancer	8.91e-05	0.000719	CcSEcCtD
Levothyroxine—Fatigue—Etoposide—prostate cancer	8.9e-05	0.000718	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—prostate cancer	8.7e-05	0.000702	CcSEcCtD
Levothyroxine—Arthralgia—Capecitabine—prostate cancer	8.67e-05	0.000699	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—prostate cancer	8.65e-05	0.000698	CcSEcCtD
Levothyroxine—Anxiety—Capecitabine—prostate cancer	8.64e-05	0.000697	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—prostate cancer	8.52e-05	0.000687	CcSEcCtD
Levothyroxine—Feeling abnormal—Etoposide—prostate cancer	8.51e-05	0.000687	CcSEcCtD
Levothyroxine—Diarrhoea—Mitoxantrone—prostate cancer	8.49e-05	0.000685	CcSEcCtD
Levothyroxine—Vomiting—Estradiol—prostate cancer	8.47e-05	0.000683	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Etoposide—prostate cancer	8.44e-05	0.000681	CcSEcCtD
Levothyroxine—Shock—Docetaxel—prostate cancer	8.44e-05	0.000681	CcSEcCtD
Levothyroxine—Rash—Estradiol—prostate cancer	8.4e-05	0.000678	CcSEcCtD
Levothyroxine—Dermatitis—Estradiol—prostate cancer	8.39e-05	0.000677	CcSEcCtD
Levothyroxine—Confusional state—Capecitabine—prostate cancer	8.38e-05	0.000676	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—prostate cancer	8.37e-05	0.000676	CcSEcCtD
Levothyroxine—Headache—Estradiol—prostate cancer	8.35e-05	0.000673	CcSEcCtD
Levothyroxine—Agitation—Prednisone—prostate cancer	8.33e-05	0.000672	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—prostate cancer	8.28e-05	0.000669	CcSEcCtD
Levothyroxine—Urticaria—Etoposide—prostate cancer	8.2e-05	0.000662	CcSEcCtD
Levothyroxine—Shock—Capecitabine—prostate cancer	8.17e-05	0.00066	CcSEcCtD
Levothyroxine—Body temperature increased—Etoposide—prostate cancer	8.16e-05	0.000659	CcSEcCtD
Levothyroxine—Abdominal pain—Etoposide—prostate cancer	8.16e-05	0.000659	CcSEcCtD
Levothyroxine—Tachycardia—Capecitabine—prostate cancer	8.11e-05	0.000654	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—prostate cancer	8.05e-05	0.00065	CcSEcCtD
Levothyroxine—Hyperhidrosis—Capecitabine—prostate cancer	8.03e-05	0.000648	CcSEcCtD
Levothyroxine—Nausea—Estradiol—prostate cancer	7.91e-05	0.000639	CcSEcCtD
Levothyroxine—Vomiting—Mitoxantrone—prostate cancer	7.89e-05	0.000637	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—prostate cancer	7.86e-05	0.000634	CcSEcCtD
Levothyroxine—Rash—Mitoxantrone—prostate cancer	7.83e-05	0.000632	CcSEcCtD
Levothyroxine—Dermatitis—Mitoxantrone—prostate cancer	7.82e-05	0.000631	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.82e-05	0.000631	CcSEcCtD
Levothyroxine—Headache—Mitoxantrone—prostate cancer	7.78e-05	0.000627	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—prostate cancer	7.76e-05	0.000626	CcSEcCtD
Levothyroxine—Arthralgia—Prednisone—prostate cancer	7.72e-05	0.000623	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—prostate cancer	7.69e-05	0.000621	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—prostate cancer	7.65e-05	0.000617	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.57e-05	0.000611	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—prostate cancer	7.56e-05	0.00061	CcSEcCtD
Levothyroxine—Insomnia—Capecitabine—prostate cancer	7.51e-05	0.000606	CcSEcCtD
Levothyroxine—Asthenia—Etoposide—prostate cancer	7.41e-05	0.000598	CcSEcCtD
Levothyroxine—Dyspnoea—Capecitabine—prostate cancer	7.41e-05	0.000598	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—prostate cancer	7.4e-05	0.000597	CcSEcCtD
Levothyroxine—Nausea—Mitoxantrone—prostate cancer	7.37e-05	0.000595	CcSEcCtD
Levothyroxine—Pruritus—Etoposide—prostate cancer	7.3e-05	0.000589	CcSEcCtD
Levothyroxine—Shock—Prednisone—prostate cancer	7.28e-05	0.000587	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—prostate cancer	7.28e-05	0.000587	CcSEcCtD
Levothyroxine—Tachycardia—Prednisone—prostate cancer	7.22e-05	0.000583	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—prostate cancer	7.2e-05	0.000581	CcSEcCtD
Levothyroxine—Fatigue—Capecitabine—prostate cancer	7.16e-05	0.000578	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisone—prostate cancer	7.15e-05	0.000577	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—prostate cancer	7.07e-05	0.000571	CcSEcCtD
Levothyroxine—Diarrhoea—Etoposide—prostate cancer	7.06e-05	0.00057	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—prostate cancer	7.02e-05	0.000566	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—prostate cancer	7e-05	0.000564	CcSEcCtD
Levothyroxine—Tension—Epirubicin—prostate cancer	6.96e-05	0.000562	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—prostate cancer	6.89e-05	0.000556	CcSEcCtD
Levothyroxine—Feeling abnormal—Capecitabine—prostate cancer	6.85e-05	0.000552	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Capecitabine—prostate cancer	6.79e-05	0.000548	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—prostate cancer	6.78e-05	0.000547	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—prostate cancer	6.78e-05	0.000547	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Prednisone—prostate cancer	6.74e-05	0.000544	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—prostate cancer	6.73e-05	0.000543	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—prostate cancer	6.69e-05	0.00054	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—prostate cancer	6.66e-05	0.000537	CcSEcCtD
Levothyroxine—Urticaria—Capecitabine—prostate cancer	6.6e-05	0.000533	CcSEcCtD
Levothyroxine—Abdominal pain—Capecitabine—prostate cancer	6.57e-05	0.00053	CcSEcCtD
Levothyroxine—Body temperature increased—Capecitabine—prostate cancer	6.57e-05	0.00053	CcSEcCtD
Levothyroxine—Vomiting—Etoposide—prostate cancer	6.56e-05	0.00053	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—prostate cancer	6.52e-05	0.000526	CcSEcCtD
Levothyroxine—Rash—Etoposide—prostate cancer	6.51e-05	0.000525	CcSEcCtD
Levothyroxine—Dermatitis—Etoposide—prostate cancer	6.5e-05	0.000525	CcSEcCtD
Levothyroxine—Headache—Etoposide—prostate cancer	6.47e-05	0.000522	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—prostate cancer	6.44e-05	0.00052	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—prostate cancer	6.38e-05	0.000515	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—prostate cancer	6.37e-05	0.000514	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—prostate cancer	6.27e-05	0.000506	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—prostate cancer	6.16e-05	0.000497	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—prostate cancer	6.14e-05	0.000496	CcSEcCtD
Levothyroxine—Nausea—Etoposide—prostate cancer	6.13e-05	0.000495	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—prostate cancer	6.1e-05	0.000492	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—prostate cancer	6.07e-05	0.00049	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—prostate cancer	6.05e-05	0.000488	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—prostate cancer	6.04e-05	0.000487	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—prostate cancer	6.03e-05	0.000487	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—prostate cancer	6.02e-05	0.000485	CcSEcCtD
Levothyroxine—Asthenia—Capecitabine—prostate cancer	5.96e-05	0.000481	CcSEcCtD
Levothyroxine—Urticaria—Prednisone—prostate cancer	5.88e-05	0.000474	CcSEcCtD
Levothyroxine—Pruritus—Capecitabine—prostate cancer	5.88e-05	0.000474	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—prostate cancer	5.87e-05	0.000474	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—prostate cancer	5.85e-05	0.000472	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—prostate cancer	5.85e-05	0.000472	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—prostate cancer	5.84e-05	0.000471	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—prostate cancer	5.8e-05	0.000468	CcSEcCtD
Levothyroxine—Shock—Epirubicin—prostate cancer	5.69e-05	0.000459	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—prostate cancer	5.68e-05	0.000459	CcSEcCtD
Levothyroxine—Diarrhoea—Capecitabine—prostate cancer	5.68e-05	0.000459	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—prostate cancer	5.65e-05	0.000456	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—prostate cancer	5.59e-05	0.000451	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—prostate cancer	5.59e-05	0.000451	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—prostate cancer	5.57e-05	0.000449	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—prostate cancer	5.46e-05	0.00044	CcSEcCtD
Levothyroxine—Rash—Docetaxel—prostate cancer	5.41e-05	0.000437	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—prostate cancer	5.41e-05	0.000436	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—prostate cancer	5.4e-05	0.000436	CcSEcCtD
Levothyroxine—Headache—Docetaxel—prostate cancer	5.38e-05	0.000434	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—prostate cancer	5.31e-05	0.000428	CcSEcCtD
Levothyroxine—Vomiting—Capecitabine—prostate cancer	5.28e-05	0.000426	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.27e-05	0.000425	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—prostate cancer	5.27e-05	0.000425	CcSEcCtD
Levothyroxine—Rash—Capecitabine—prostate cancer	5.24e-05	0.000423	CcSEcCtD
Levothyroxine—Pruritus—Prednisone—prostate cancer	5.24e-05	0.000422	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—prostate cancer	5.23e-05	0.000422	CcSEcCtD
Levothyroxine—Dermatitis—Capecitabine—prostate cancer	5.23e-05	0.000422	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—prostate cancer	5.23e-05	0.000422	CcSEcCtD
Levothyroxine—Headache—Capecitabine—prostate cancer	5.2e-05	0.00042	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—prostate cancer	5.18e-05	0.000418	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—prostate cancer	5.16e-05	0.000416	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—prostate cancer	5.1e-05	0.000411	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—prostate cancer	5.06e-05	0.000409	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—prostate cancer	4.99e-05	0.000403	CcSEcCtD
Levothyroxine—Nausea—Capecitabine—prostate cancer	4.93e-05	0.000398	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.88e-05	0.000394	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—prostate cancer	4.84e-05	0.000391	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—prostate cancer	4.77e-05	0.000385	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—prostate cancer	4.77e-05	0.000385	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—prostate cancer	4.73e-05	0.000382	CcSEcCtD
Levothyroxine—Vomiting—Prednisone—prostate cancer	4.7e-05	0.00038	CcSEcCtD
Levothyroxine—Rash—Prednisone—prostate cancer	4.67e-05	0.000377	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—prostate cancer	4.66e-05	0.000376	CcSEcCtD
Levothyroxine—Headache—Prednisone—prostate cancer	4.64e-05	0.000374	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—prostate cancer	4.62e-05	0.000373	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—prostate cancer	4.6e-05	0.000371	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—prostate cancer	4.58e-05	0.000369	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—prostate cancer	4.58e-05	0.000369	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—prostate cancer	4.41e-05	0.000356	CcSEcCtD
Levothyroxine—Nausea—Prednisone—prostate cancer	4.4e-05	0.000355	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—prostate cancer	4.38e-05	0.000353	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—prostate cancer	4.25e-05	0.000343	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—prostate cancer	4.23e-05	0.000342	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—prostate cancer	4.23e-05	0.000342	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—prostate cancer	4.15e-05	0.000335	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—prostate cancer	4.09e-05	0.00033	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—prostate cancer	3.96e-05	0.00032	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—prostate cancer	3.84e-05	0.00031	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—prostate cancer	3.79e-05	0.000306	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—prostate cancer	3.68e-05	0.000297	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—prostate cancer	3.66e-05	0.000296	CcSEcCtD
Levothyroxine—Rash—Epirubicin—prostate cancer	3.65e-05	0.000294	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—prostate cancer	3.65e-05	0.000294	CcSEcCtD
Levothyroxine—Headache—Epirubicin—prostate cancer	3.63e-05	0.000293	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—prostate cancer	3.44e-05	0.000277	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—prostate cancer	3.4e-05	0.000275	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—prostate cancer	3.38e-05	0.000272	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—prostate cancer	3.37e-05	0.000272	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—prostate cancer	3.35e-05	0.000271	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—prostate cancer	3.18e-05	0.000257	CcSEcCtD
Levothyroxine—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.68e-06	3.63e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PRKACB—prostate cancer	3.68e-06	3.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKR1C3—prostate cancer	3.67e-06	3.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PRKACB—prostate cancer	3.65e-06	3.6e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP17A1—prostate cancer	3.64e-06	3.58e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA3—prostate cancer	3.62e-06	3.57e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP17A1—prostate cancer	3.62e-06	3.56e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—prostate cancer	3.61e-06	3.55e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—JAK2—prostate cancer	3.6e-06	3.54e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.59e-06	3.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.58e-06	3.53e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—prostate cancer	3.57e-06	3.52e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.57e-06	3.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACSL4—prostate cancer	3.51e-06	3.46e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.51e-06	3.46e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—INS—prostate cancer	3.5e-06	3.45e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—prostate cancer	3.5e-06	3.45e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—prostate cancer	3.49e-06	3.44e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAV1—prostate cancer	3.47e-06	3.42e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA2—prostate cancer	3.47e-06	3.42e-05	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—prostate cancer	3.46e-06	3.41e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—HPGDS—prostate cancer	3.45e-06	3.4e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA2—prostate cancer	3.45e-06	3.4e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2C19—prostate cancer	3.43e-06	3.38e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CREBBP—prostate cancer	3.43e-06	3.38e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—prostate cancer	3.42e-06	3.37e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—prostate cancer	3.42e-06	3.37e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ARG2—prostate cancer	3.37e-06	3.32e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UMPS—prostate cancer	3.37e-06	3.32e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PHGDH—prostate cancer	3.37e-06	3.32e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTT1—prostate cancer	3.35e-06	3.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ACHE—prostate cancer	3.35e-06	3.3e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.32e-06	3.27e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2A6—prostate cancer	3.31e-06	3.26e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC5A5—prostate cancer	3.31e-06	3.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LDHB—prostate cancer	3.3e-06	3.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	3.3e-06	3.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC5A5—prostate cancer	3.29e-06	3.24e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—prostate cancer	3.25e-06	3.2e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	3.25e-06	3.2e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.24e-06	3.19e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—prostate cancer	3.23e-06	3.18e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2E1—prostate cancer	3.23e-06	3.18e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKR1C3—prostate cancer	3.22e-06	3.17e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2E1—prostate cancer	3.21e-06	3.16e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PRKACB—prostate cancer	3.2e-06	3.16e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NQO1—prostate cancer	3.19e-06	3.15e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NQO1—prostate cancer	3.18e-06	3.13e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP17A1—prostate cancer	3.17e-06	3.12e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	3.16e-06	3.12e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TH—prostate cancer	3.15e-06	3.1e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IL2—prostate cancer	3.14e-06	3.09e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.13e-06	3.09e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TH—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PDHA1—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA3—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—UCP3—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TCN2—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.13e-06	3.08e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—prostate cancer	3.12e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.11e-06	3.07e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.11e-06	3.06e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.1e-06	3.05e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP3A4—prostate cancer	3.1e-06	3.05e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.08e-06	3.04e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NOS3—prostate cancer	3.07e-06	3.03e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.06e-06	3.02e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1B1—prostate cancer	3.04e-06	3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA2—prostate cancer	3.02e-06	2.98e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—INS—prostate cancer	2.99e-06	2.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.98e-06	2.94e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.98e-06	2.94e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—EP300—prostate cancer	2.97e-06	2.93e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—prostate cancer	2.97e-06	2.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GGT1—prostate cancer	2.97e-06	2.92e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GGT1—prostate cancer	2.95e-06	2.91e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CREBBP—prostate cancer	2.93e-06	2.89e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NCOA1—prostate cancer	2.92e-06	2.88e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NCOA1—prostate cancer	2.9e-06	2.86e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC5A5—prostate cancer	2.88e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP19A1—prostate cancer	2.88e-06	2.84e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—prostate cancer	2.87e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP19A1—prostate cancer	2.86e-06	2.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA4—prostate cancer	2.86e-06	2.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.86e-06	2.82e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—prostate cancer	2.83e-06	2.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EP300—prostate cancer	2.81e-06	2.77e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2E1—prostate cancer	2.81e-06	2.77e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—prostate cancer	2.81e-06	2.77e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.79e-06	2.75e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NQO1—prostate cancer	2.78e-06	2.74e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	2.78e-06	2.74e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—RXRA—prostate cancer	2.78e-06	2.74e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—RXRA—prostate cancer	2.76e-06	2.72e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.75e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.75e-06	2.71e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TH—prostate cancer	2.74e-06	2.7e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—prostate cancer	2.74e-06	2.7e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP3A4—prostate cancer	2.71e-06	2.67e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.7e-06	2.66e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.69e-06	2.65e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.69e-06	2.65e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—COMT—prostate cancer	2.68e-06	2.64e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1B1—prostate cancer	2.67e-06	2.63e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—prostate cancer	2.67e-06	2.63e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTP1—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—COMT—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NAT2—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTP1—prostate cancer	2.65e-06	2.61e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—prostate cancer	2.63e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NOS3—prostate cancer	2.63e-06	2.59e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ITPR1—prostate cancer	2.62e-06	2.58e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ITPR1—prostate cancer	2.61e-06	2.57e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GGT1—prostate cancer	2.58e-06	2.55e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.58e-06	2.54e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.56e-06	2.52e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.55e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LRP2—prostate cancer	2.55e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.55e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NCOA1—prostate cancer	2.54e-06	2.51e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP19A1—prostate cancer	2.51e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—P4HB—prostate cancer	2.5e-06	2.46e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—prostate cancer	2.48e-06	2.44e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—prostate cancer	2.46e-06	2.43e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—prostate cancer	2.45e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GSTM1—prostate cancer	2.45e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—prostate cancer	2.45e-06	2.41e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GSTM1—prostate cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.43e-06	2.4e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—prostate cancer	2.43e-06	2.39e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	2.42e-06	2.39e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—RXRA—prostate cancer	2.42e-06	2.39e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—LPL—prostate cancer	2.4e-06	2.37e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—prostate cancer	2.4e-06	2.37e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—LPL—prostate cancer	2.39e-06	2.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.37e-06	2.34e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—EP300—prostate cancer	2.34e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MED12—prostate cancer	2.33e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—COMT—prostate cancer	2.33e-06	2.3e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTP1—prostate cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GNG5—prostate cancer	2.31e-06	2.28e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP1A1—prostate cancer	2.31e-06	2.27e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ERCC2—prostate cancer	2.3e-06	2.27e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ERCC2—prostate cancer	2.29e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ITPR1—prostate cancer	2.28e-06	2.25e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—prostate cancer	2.27e-06	2.23e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.23e-06	2.2e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—prostate cancer	2.2e-06	2.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—MTHFR—prostate cancer	2.16e-06	2.13e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—prostate cancer	2.16e-06	2.13e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—MTHFR—prostate cancer	2.15e-06	2.12e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GSTM1—prostate cancer	2.13e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.13e-06	2.1e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARA—prostate cancer	2.12e-06	2.09e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.11e-06	2.08e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARA—prostate cancer	2.11e-06	2.08e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—prostate cancer	2.09e-06	2.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—LPL—prostate cancer	2.09e-06	2.06e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—prostate cancer	2.08e-06	2.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ACHE—prostate cancer	2.06e-06	2.03e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.06e-06	2.03e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.04e-06	2.01e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.02e-06	1.99e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—prostate cancer	2.01e-06	1.98e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ERCC2—prostate cancer	2e-06	1.98e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—EP300—prostate cancer	2e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAV1—prostate cancer	2e-06	1.97e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAV1—prostate cancer	1.98e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.98e-06	1.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.97e-06	1.94e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.95e-06	1.92e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.91e-06	1.88e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.9e-06	1.87e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—MTHFR—prostate cancer	1.88e-06	1.86e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.86e-06	1.83e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARA—prostate cancer	1.85e-06	1.82e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.82e-06	1.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—prostate cancer	1.81e-06	1.78e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—prostate cancer	1.8e-06	1.77e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.77e-06	1.75e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAV1—prostate cancer	1.74e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.73e-06	1.71e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—prostate cancer	1.73e-06	1.7e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—INS—prostate cancer	1.72e-06	1.7e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NQO1—prostate cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—INS—prostate cancer	1.71e-06	1.69e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—prostate cancer	1.7e-06	1.68e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TH—prostate cancer	1.69e-06	1.66e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.69e-06	1.66e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CREBBP—prostate cancer	1.68e-06	1.65e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.64e-06	1.62e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.6e-06	1.57e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GGT1—prostate cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—prostate cancer	1.59e-06	1.57e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.58e-06	1.56e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.57e-06	1.54e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.55e-06	1.52e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NOS3—prostate cancer	1.51e-06	1.49e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NOS3—prostate cancer	1.5e-06	1.48e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—INS—prostate cancer	1.5e-06	1.48e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—RXRA—prostate cancer	1.49e-06	1.47e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	1.48e-06	1.46e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CREBBP—prostate cancer	1.47e-06	1.45e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—COMT—prostate cancer	1.44e-06	1.42e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.43e-06	1.41e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—prostate cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.41e-06	1.39e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.37e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—prostate cancer	1.38e-06	1.36e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.38e-06	1.36e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—prostate cancer	1.37e-06	1.35e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—prostate cancer	1.33e-06	1.31e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NOS3—prostate cancer	1.31e-06	1.3e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.31e-06	1.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—LPL—prostate cancer	1.29e-06	1.27e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.25e-06	1.23e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.24e-06	1.22e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.2e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—prostate cancer	1.21e-06	1.19e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—prostate cancer	1.2e-06	1.19e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—prostate cancer	1.2e-06	1.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—prostate cancer	1.2e-06	1.18e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.16e-06	1.14e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—EP300—prostate cancer	1.15e-06	1.13e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—EP300—prostate cancer	1.14e-06	1.12e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARA—prostate cancer	1.14e-06	1.12e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAV1—prostate cancer	1.07e-06	1.06e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—prostate cancer	1.05e-06	1.03e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—EP300—prostate cancer	1e-06	9.85e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—prostate cancer	9.76e-07	9.61e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—INS—prostate cancer	9.23e-07	9.1e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CREBBP—prostate cancer	9.04e-07	8.91e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—prostate cancer	8.58e-07	8.45e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—prostate cancer	8.49e-07	8.37e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—prostate cancer	8.44e-07	8.32e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NOS3—prostate cancer	8.1e-07	7.98e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—prostate cancer	7.47e-07	7.37e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—prostate cancer	7.41e-07	7.3e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—prostate cancer	7.4e-07	7.29e-06	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—prostate cancer	6.94e-07	6.83e-06	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—prostate cancer	6.9e-07	6.8e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—prostate cancer	6.46e-07	6.36e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—EP300—prostate cancer	6.16e-07	6.07e-06	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—prostate cancer	6.04e-07	5.95e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.56e-07	4.49e-06	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—prostate cancer	3.72e-07	3.67e-06	CbGpPWpGaD
